CAD 0.22
(4.76%)
Year | Revenue | Revenue Growth |
---|---|---|
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | -100.0% |
2015 | 24.73 Million CAD | -20.21% |
2014 | 30.99 Million CAD | -50.81% |
2013 | 63.01 Million CAD | 17.14% |
2012 | 53.79 Million CAD | 372.5% |
2011 | 11.38 Million CAD | 108.39% |
2010 | 5.46 Million CAD | 15651.21% |
2009 | 34.68 Thousand CAD | -90.0% |
2008 | 346.75 Thousand CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 Q2 | - CAD | 100.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | -1000.00 CAD | -100.02% |
2016 Q3 | - CAD | 0.0% |
2016 FY | - CAD | -100.0% |
2015 Q2 | 10.77 Million CAD | 52.66% |
2015 Q3 | 9.43 Million CAD | -12.51% |
2015 Q4 | 4.52 Million CAD | -52.03% |
2015 FY | 24.73 Million CAD | -20.21% |
2015 Q1 | 7.06 Million CAD | 4.22% |
2014 Q1 | 13.96 Million CAD | -9.21% |
2014 Q4 | 6.77 Million CAD | -15.88% |
2014 Q3 | 8.05 Million CAD | -11.57% |
2014 Q2 | 9.1 Million CAD | -34.77% |
2014 FY | 30.99 Million CAD | -50.81% |
2013 FY | 63.01 Million CAD | 17.14% |
2013 Q3 | 17.22 Million CAD | 4.71% |
2013 Q4 | 15.38 Million CAD | -10.7% |
2013 Q2 | 16.44 Million CAD | -6.18% |
2013 Q1 | 17.53 Million CAD | 17.63% |
2012 Q3 | 9.72 Million CAD | -16.32% |
2012 Q4 | 14.9 Million CAD | 53.19% |
2012 FY | 53.79 Million CAD | 372.5% |
2012 Q2 | 11.62 Million CAD | 180.58% |
2012 Q1 | 4.14 Million CAD | 0.41% |
2011 Q1 | 1.28 Million CAD | -25.43% |
2011 Q4 | 4.12 Million CAD | 72.95% |
2011 Q2 | 2.57 Million CAD | 99.93% |
2011 Q3 | 2.38 Million CAD | -7.27% |
2011 FY | 11.38 Million CAD | 108.39% |
2010 FY | 5.46 Million CAD | 15651.21% |
2010 Q3 | 1.98 Million CAD | 327.2% |
2010 Q2 | 464.74 Thousand CAD | 1223105.26% |
2010 Q1 | -38.00 CAD | -101.04% |
2010 Q4 | 1.72 Million CAD | -13.06% |
2009 FY | 34.68 Thousand CAD | -90.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q4 | 3653.00 CAD | -63.67% |
2009 Q2 | - CAD | 0.0% |
2009 Q3 | 10.05 Thousand CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 FY | 346.75 Thousand CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
MustGrow Biologics Corp. | 4.71 Million CAD | 100.0% |